The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt

Author： Gills Joell J   Dennis Phillip A  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.7, 2004-07, pp. : 787-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments in Selective Small Molecule ATP-Targeting the Serine/Threonine Kinase Akt/PKB

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 13, 2011-01 ,pp. : 1093-1107

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2839-2854

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Serine / Threonine Protein Kinase B / Akt and Cell-cycle Checkpoint Kinases for Treating Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 939-971

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphatidylinositol analogues that block the activation of Akt for the treatment of cancer

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1379-1383

Informa Healthcare

Access to resources Recommend Favorite

Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice

By Moncada A.   Cendan C.M.   Baeyens J.M.   Del Pozo E.  

European Journal of Pharmacology, Vol. 465, Iss. 1, 2003-03 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite